Skip to main content

Table 3 Clinical symptoms before and after amikacin treatment (Number [%])

From: The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases

Clinical symptom

Before treatment

(n = 23)

After treatment

(n = 23)

P valuea

Cough

22 (95.7)

16 (69.6)

0.0412

Sputum

22 (95.7)

12 (52.2)

0.0044

Dyspnea

15 (65.2)

14 (60.9)

>0.99

Hemoptysis

5 (21.7)

3 (13.0)

0.4795

Fever

1 (4.3)

0

>0.99

  1. aMcNemar’s test